Abstract
E3 ubiquitin ligases are important protein-modifying enzymes involved in the pathogenesis of a variety of neurodegenerative diseases. F-box and leucine-rich repeat protein 20 (FBXL20), an E3 ubiquitin ligase widely expressed in the central nervous system, plays an important role in the ubiquitin-dependent degradation of regulating synaptic membrane exocytosis 1 (RIM1), which is an important factor in the release of synaptic vesicles. FBXL20 has been associated with a variety of neurodegenerative diseases; thus, we hypothesized that FBXL20 is involved in the development of epilepsy. Herein, we used immunofluorescence staining, immunohistochemistry and western blotting to determine the expression pattern of FBXL20 in temporal lobe epilepsy patients and pilocarpine-induced epilepsy animal models. We also injected SD rats with lentivirus-vector mediated overexpression of FBXL20. The results showed that FBXL20 is expressed in the membrane and the cytoplasm of cortical neurons, and overexpression of FBXL20 decreased the onset level of spontaneous seizure, the frequency and duration of seizures. Additionally, FBXL20 protein level was decreased but RIM1 protein level was increased in the epileptic group compared with the LV-FBXL20 and LV-GFP group. These findings in humans were consistent with the results from a pilocarpine-induced animal model of chronic epilepsy. Thus, abnormal expression of FBXL20 might play an important role in the development of epilepsy.
Similar content being viewed by others
Abbreviations
- FBXL20:
-
F-box and leucine-rich repeat protein 20
- Rim1:
-
Regulating synaptic membrane exocytosis 1
- TLE:
-
Temporal lobe epilepsy
- CNS:
-
Central nervous system
- UPS:
-
Ubiquitin-proteasome system
- AEDs:
-
Anti-epileptic drugs
- EEG:
-
Electroencephalography
- F:
-
Female
- M:
-
Male
- VPA:
-
Valproate
- PB:
-
Phenobarbital
- CBZ:
-
Carbamazepine
- TPM:
-
Topiramate
- PHT:
-
Phenytoin
- LTG:
-
Lamotrigine
- OXC:
-
Oxcarbazepine
- LEV:
-
Levetiracetam
- TN:
-
Temporal neocortex
- l:
-
Left
- r:
-
Right
- NL:
-
Neuronal necrosis
- G:
-
Gliosis
- SD rats:
-
Sprague-Dawley rats
- IHC:
-
Immunohistochemical
- IF:
-
Immunofluorescence
- MRI:
-
Magnetic resonance imaging
- SE:
-
Status epilepticus
- RT-PCR:
-
Real-time PCR
References
Leach JP, Abassi H (2013) Modern management of epilepsy. Clin Med 13(1):84–86
Bae YS, Chung W, Han K et al (2013) Down-regulation of RalBP1 expression reduces seizure threshold and synaptic inhibition in mice. Biochem Biophys Res Commun 433(2):175–180
Dulac O, Milh M, Holmes GL (2012) Brain maturation and epilepsy. Handbook Clin Neurol 111:441–446
Yang X, Xu X, Zhang Y et al (2015) Altered expression of intersectin1-L in patients with refractory epilepsy and in experimental epileptic rats. Cell Mol Neurobiol 35(6):871–880
Cousin MA, Robinson PJ (1999) Mechanisms of synaptic vesicle recycling illuminated by fluorescent dyes. J Neurochem 3(6):2227–2239
Yao I, Takagi H, Ageta H et al (2007) SCRAPPER-dependent ubiquitination of active zone protein RIM1 regulates synaptic vesicle release. Cell 130(5):943–957
] Pitsch J, Opitz T, Borm V et al (2012) The presynaptic active zone protein RIM1α controls epileptogenesis following status epilepticus. J Neurosci 32(36):12384–12395
Martin BS, Huntsman MM (2012) Pathological plasticity in fragile X syndrome. Neural Plast. doi:10.1155/2012/275630
Holderith N, Lorincz A, Katona G et al (2012) Release probability of hippocampal glutamatergic terminals scales with the size of the active zone. Nat Neurosci 15(7):988–997
Upreti C, Otero R, Partida C et al (2012) Altered neurotransmitter release, vesicle recycling and presynaptic structure in the pilocarpine model of temporal lobe epilepsy. Brain 135(3):869–885
Crabtree GW, Gogos JA (2014) Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia. Front Synaptic Neurosci 6:28
Minassian BA, Lee JR, Herbrick JA et al (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 20(2):171–174
Minassian BA (2002) Progressive myoclonus epilepsy with polyglucosan bodies: lafora disease. Advan Neurol 89:199
Chan EM, Young EJ, Ianzano L et al (2003) Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 35(2):125–127
Girach F, Craig TJ, Rocca DL et al (2013) RIM1α SUMOylation is required for fast synaptic vesicle exocytosis. Cell Reports 5(5):1294–1301
Wu L, Peng J, Kong H et al (2015) The role of ubiquitin/Nedd4-2 in the pathogenesis of mesial temporal lobe epilepsy. Physiol Behav 143:104–112
Liu J, Ye J, Zou X et al (2014) CRL4ACRBN E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis. Nat Commun 5:3924
Yao I, Takao K, Miyakawa T et al (2011) Synaptic E3 ligase SCRAPPER in contextual fear conditioning: extensive behavioral phenotyping of Scrapper heterozygote and overexpressing mutant mice. PLoS One 6(2):e17317
Jin J, Cardozo T, Lovering RC et al (2004) Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev 18(21):2573–2580
Kintscher M, Wozny C, Johenning FW et al (2013) Role of RIM1α in short- and long-term synaptic plasticity at cerebellar parallel fibres. Nat Commun 4:2392
Kiyonaka S, Wakamori M, Miki T et al (2007) RIM1 confers sustained activity and neurotransmitter vesicle anchoring to presynaptic Ca2+ channels. Nat Neurosci 10(6):691–701
Schoch S, Castillo PE, Jo T et al (2002) RIM1α forms a protein scaffold for regulating neurotransmitter release at the active zone. Nature 415(6869):321–326
Han Y, Kaeser PS, Südhof TC et al (2011) RIM determines Ca2+ channel density and vesicle docking at the presynaptic active zone. Neuron 69(2):304–316
Weiss N, Sandoval A, Kyonaka S et al (2011) Rim1 modulates direct G-protein regulation of CaV2.2 channels, Pflügers Arch 461(4):447–459
Acknowledgments
This work was supported by the Foundation of Chongqing Health Bureau (2013-1-005), and supported by the National key clinical specialty construction projects [2011-170]. We sincerely thank the support of Xuanwu Hospital and Tiantan Hospital of Capital Medical University, Xinqiao Hospital of the Third Military Medical University, and the First Affiliated Hospital of Chongqing Medical University, which provided the brain tissue samples. We also feel grateful for the patients and their families who participated in this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in the study involving human participants were in accordance with the ethical standards of the Chongqing Medical University and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Fu, P., Wen, Y., Xiong, Y. et al. Abnormal Expression of FBXL20 in Refractory Epilepsy Patients and a Pilocarpine-Induced Rat Model. Neurochem Res 41, 3020–3031 (2016). https://doi.org/10.1007/s11064-016-2021-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-016-2021-y